Key Events This Week
1 June: Stellar Q4 FY26 results announced with 112% profit surge
2 June: New 52-week and all-time highs reached, intraday peak at Rs.1,285.7
2 June: Exceptional trading volumes and institutional interest recorded
3 June: Technical momentum sustains with bullish indicators and strong market returns
5 June: Week closes at Rs.1,202.15, down 7.29% on the day but up sharply for the week
Rubicon Research Ltd is Rated Strong Buy
2026-06-13 10:10:51Rubicon Research Ltd is rated Strong Buy by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 13 June 2026, providing investors with the most up-to-date insights into the company’s performance and outlook.
Read full news articleRubicon Research Ltd Gains 7.67%: 3 Key Factors Driving the Surge
2026-06-13 09:01:53
Key Events This Week
8 Jun: Stock opens at ₹1,178.85 amid technical momentum shift
9 Jun: Technical momentum shifts amid strong market outperformance
10 Jun: Reports strong quarterly financial turnaround with record revenue and margin gains
11 Jun: Hits intraday high with 7.25% surge to ₹1,264.35
12 Jun: Week closes at ₹1,294.35, up 0.52% on the day
Rubicon Research Ltd Surges 7.25% to Day's High of Rs 1264.35 — Outperforms Sector by 5.18 Percentage Points
2026-06-11 10:31:25While the Sensex edged lower by 0.04% on 11 Jun 2026, Rubicon Research Ltd surged 7.25%, marking a standout session in the Pharmaceuticals & Biotechnology sector with a 5.18 percentage-point outperformance. This sharp intraday gain rewrites the short-term narrative for the small-cap stock, raising questions about the sustainability and nature of this rally.
Read full news articleRubicon Research Ltd Reports Strong Quarterly Financial Turnaround with Robust Revenue and Margin Gains
2026-06-10 15:00:46Rubicon Research Ltd has delivered an exceptional quarterly performance in March 2026, marking a significant turnaround in its financial trend. The pharmaceutical and biotechnology company’s latest results showcase record-breaking revenue, profit margins, and earnings per share, prompting a strong buy rating upgrade and signalling robust growth prospects ahead.
Read full news articleRubicon Research Ltd Technical Momentum Shifts Amid Strong Market Outperformance
2026-06-09 08:06:06Rubicon Research Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance. Despite a slight dip in the daily price, key indicators such as the MACD and Bollinger Bands suggest underlying strength, while the RSI signals caution. This article analyses the recent technical parameter changes and their implications for investors.
Read full news articleRubicon Research Ltd Surges on Bullish Technical Momentum and Strong Market Returns
2026-06-03 08:07:28Rubicon Research Ltd has demonstrated a remarkable price momentum shift, supported by a strong technical upgrade and a significant surge in market performance. The pharmaceutical and biotechnology small-cap stock has been re-rated to a Strong Buy with a Mojo Score of 90.0, reflecting robust bullish signals across multiple technical indicators and a substantial outperformance relative to the Sensex.
Read full news articleRubicon Research Ltd Surges 9.95% to Day's High of Rs 1285.7 — Outperforms Sector by 10.56 Percentage Points
2026-06-02 14:17:16The Sensex gained a modest 0.75% on 2 Jun 2026, while Rubicon Research Ltd surged 9.95%, outperforming its Pharmaceuticals & Biotechnology sector by 10.56 percentage points. This sharp single-session advance, which pushed the stock to a new 52-week and all-time high of Rs 1285.7, signals a strong momentum continuation rather than a mere technical bounce.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
02-Jun-2026 | Source : BSEEarning Call Transcript
Earnings Call Audio Recording
30-May-2026 | Source : BSEEarnings Call Audio Recording
Announcement under Regulation 30 (LODR)-Newspaper Publication
30-May-2026 | Source : BSERubicon Newspaper Publication under reg 30
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






